Our goal is to understand and exploit the immunogenic properties of tumor irradiation in integrating it with immunotherapy to improve cancer patient outcome. Read more >>

Clinical Trials

We are currently involved in a number of both i-SAbR and SBRT clinical trials. Learn more >>

Meet the PI

Raquibul Hannan, M.D., Ph.D.


Contact Us

Phone: 214-645-0879